{"id":79820,"date":"2026-04-21T12:05:18","date_gmt":"2026-04-21T12:05:18","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"},"modified":"2026-04-21T12:05:18","modified_gmt":"2026-04-21T12:05:18","slug":"spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","title":{"rendered":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium"},"content":{"rendered":"<div>\n<p>LONDON, April  21, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XaPDmvIK2RcxySj4gswpMSjSAGfeHa-WnqDyplvkRXMfkgksPLO5IRhvcJcAJOX7Vk1Luz55fN2y2V99aVMHa-4GKRnP3FAZZbNzEeeoL80=\" rel=\"nofollow\" target=\"_blank\" title=\"Spur Therapeutics\">Spur Therapeutics<\/a> today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy.<\/p>\n<p>Presentation details:<\/p>\n<p><strong>Oral presentation:<\/strong><\/p>\n<p><strong>Title:<\/strong> Two-year follow up of avigbagene parvec (FLT201) investigational AAV gene therapy in adults with Gaucher Disease type 1: Results from GALILEO-1 and GALILEO-2 <br \/><strong>Session 7: <\/strong>Therapies in Gaucher Disease <em>(also available as a poster)<\/em><br \/><strong>Date &amp; Time: <\/strong>Wednesday May 6, 09:45 &#8211; 10:00 <br \/><strong>Presenter:\u00a0<\/strong>Ida Schwartz, MD,\u00a0PhD,\u00a0Hospital de Clinicas de Porto Alegre, Brazil<\/p>\n<p><strong>Poster presentations:<\/strong><\/p>\n<p><strong>Title: <\/strong>Trial in Progress: GALILEO-3, a Phase 3 Registrational Trial of avigbagene parvec\u00a0(FLT201) Gene Therapy Candidate in Patients with Gaucher Disease type 1<br \/><strong>Presenter:<\/strong> Reena Sharma, MD, Salford Royal Hospital, UK<\/p>\n<p><strong>Title: <\/strong>Impact of avigbagene parvec (FLT201) on markers of bone health in adults with Gaucher disease type 1<br \/><strong>Presenter:<\/strong> Pilar Giraldo, MD, PhD, Hospital Universitario Quironsalud, Zaragoza, Spain<\/p>\n<p>For more details on the symposium, please visit the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lOQh1srQ0205uj3f1Pd4zkboloZWVnYSytPNWP4DfoDk-iLD3yOXh_-Tq1jYx__YGN22Qy8RBMH7IlV3nRYhSynhaKRsPwiE1BznbcTkTjrHZsB53sB33b_qU4T-tlmgQQGjSPkAvwRuFa_CYrNAMw==\" rel=\"nofollow\" target=\"_blank\" title=\"IWGGD Symposium website\">IWGGD Symposium website<\/a>.<\/p>\n<p><strong>About Spur Therapeutics<\/strong>\u00a0<br \/>Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions. By optimizing every component of its product candidates, Spur aims to unlock the true potential of gene therapy to realize outsized clinical results. Spur is advancing a breakthrough gene therapy candidate for Gaucher disease and disease and a preclinical gene therapy candidate for Parkinson\u2019s disease. Expanding our impact, and advancing the practice of genetic medicine.\u00a0<\/p>\n<p>Toward life-changing therapies, and brighter futures. Toward More&#x2122;\u00a0<\/p>\n<p>For more information, visit\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=asO3fGKC74kVzvM8VeNe08w9E7XDN7t4u7BgZ4IBi-LTqipt-ARnezcJFLYp-Js2rhsirgJt1SX7EQYnEfIekRGxBER_ltlugZkMKeTxebRezfzLn9m2O-HbWwWfTyUi2ZgYk-pO8aYZDl9oaxPhHLge0h8X_N9IVo9-10FIGSvacp8q-y1kK5efwFO6I5MNnn3jbVgERSnPVcAnbug80LdLMusXbv-rWO9NZ8LULZAHiSL8wwgV5aECGMrOfXkFTTwAHVHADUHu2NXtSr1qfCqFPEgrqkbh-bJz-anDLH5eszkgPPZqzRUnmUxbHMkdVxN5Cvfv28oe2OUviJIxvLvhW-tYjXUKjJnwwkJmKKCwMWXwOulfBs6ugVnr061pV2j36-7xIJXYX9iG4JRjQYIBy4VnW4YoWhYhFIKLWP9iXf_tu3aJitn2wtW9WK58Fm9MilPG_JR6TG4TH9FxnJrkTUznIqHi0JRfzW9W2iwn06qxXXBnXG0Y6Ynd5iTw\" rel=\"nofollow\" target=\"_blank\" title=\"www.spurtherapeutics.com\">www.spurtherapeutics.com<\/a>\u202for connect with Spur on\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hRe8OqWFrzzMpm_DtjEqZP-8laWzpEvwDbiqS2TNoocq6oM8nfRY-Fx71LJExOyKddceK05zmtop8LXym0RX9HRCxVaIbRfDdLRK1VfxAAYIVb-lMblH6u54-tUuGgBHOp2fpoUh0Np0pmw7d0-PW1PK51yRELmCAWqmFuMRuV6fGBoLNVH2EJysAgjcmH8UFAMrjuMuCldulgNyYVrvmGUFgu-JM5XFYORTDInmvVi3_7cZfe5hWtZEvpXtd1wcwh8PulI5tu1kMFpBiNoQlOy8CdaO3YzFDc38Mbe-m8QcJY6LRDNv6oXmlzEscS0ftSlmHBHOGZrJxo12U9ewcrrKEU40j64EuY9vYzU1ZsqLY-KG_KZw7lkRP3HYCwtecM8J1mtJJzNGoOmrHlGlxQ8LnpeYpLx2vH1fMPu3L_bhfo_WKPXLdGq0xGlTGSY3CN3nVEoEJdZqwgZ6mUc29PbeXFAmx9M3DXBtxlS2n1o=\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a>.\u00a0<\/p>\n<p><strong>Contact<\/strong>\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tI7w75FskbeWEYcymYJlmnmQlZDqc9cQVZQ2lYWh29eTqTr0LUzDHXm8Enup0nhnrsBXr0CRbsCaEcnH0lqo6jfmHARGtCmklDp5Z5touEn53eY7rsKDUgaeL-D_GrFt\" rel=\"nofollow\" target=\"_blank\" title=\"media@spurtherapeutics.com\">media@spurtherapeutics.com<\/a>\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Yjk5Y2U5ODctYmEyNC00ODNlLTgzNmItYzJjODE4ZjM3N2Q1LTEyNzQ1MDEtMjAyNi0wNC0yMS1lbg==\/tiny\/Spur-Therapeutics.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON, April 21, 2026 (GLOBE NEWSWIRE) &#8212; Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GALILEO-2 trials of avigbagene parvec (FLT201), its investigational gene therapy for Gaucher disease type 1, during the International Working Group on Gaucher Disease (IWGGD)\u00a02026 Symposium, May 3-6, 2026 in Trieste, Italy. Presentation details: [&#8230;]\n","protected":false},"author":1,"featured_media":79821,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-79820","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\" \/>\n<meta property=\"og:description\" content=\"LONDON, April 21, 2026 (GLOBE NEWSWIRE) &#8212; Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T12:05:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1075\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\",\"datePublished\":\"2026-04-21T12:05:18+00:00\",\"dateModified\":\"2026-04-21T12:05:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\"},\"wordCount\":292,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\",\"name\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-04-21T12:05:18+00:00\",\"dateModified\":\"2026-04-21T12:05:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium","og_description":"LONDON, April 21, 2026 (GLOBE NEWSWIRE) &#8212; Spur Therapeutics today announced the presentation of new insights from its Phase 1\/2 GALILEO-1 and GA","og_url":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-04-21T12:05:18+00:00","og_image":[{"width":1075,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/04\/sgb-media-kit-2026.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium","datePublished":"2026-04-21T12:05:18+00:00","dateModified":"2026-04-21T12:05:18+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"},"wordCount":292,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","url":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/","name":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-04-21T12:05:18+00:00","dateModified":"2026-04-21T12:05:18+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/spur-therapeutics-to-present-new-clinical-data-on-flt201-for-gaucher-disease-during-the-iwggd-2026-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Spur Therapeutics To Present New Clinical Data on FLT201 for Gaucher Disease during the IWGGD 2026 Symposium"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=79820"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79820\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/79821"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=79820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=79820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=79820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}